EEG seizure activity and behavioral neurotoxicity produced by (+)-MK801, but not the glycine site antagonist L-687,414, in the rat

This publication has 15 references indexed in Scilit:

• The Neuroprotective Effect of the Glycine Site Antagonist 3R-(+)-cis-4-Methyl-HA966 (L-687,414) in a Rat Model of Focal Ischaemia
  Journal of Cerebral Blood Flow & Metabolism, 1995
• The Glycine Site on the NMDA Receptor: Structure-Activity Relationships and Therapeutic Potential
  Journal of Medicinal Chemistry, 1994
• Lack of effect of L‐687,414 ((+)‐cis‐4‐methyl‐HA‐966)₅ an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology
  British Journal of Pharmacology, 1993
• Chapter 9 NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation
  Published by Elsevier ,1993
• The glycine site of the NMDA receptor — five years on
  Trends in Pharmacological Sciences, 1993
• Neurotoxin‐Related Research: From the Laboratory to the Clinic
  Annals of the New York Academy of Sciences, 1992
• D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia
  Neuropharmacology, 1990
• Effects of five-membered ring conformation on bioreceptor recognition: identification of 3R-amino-1-hydroxy-4R-methylpyrrolidin-2-one (L-687,414) as a potent glycine/N-methyl-D-aspartate receptor antagonist
  Journal of the Chemical Society, Chemical Communications, 1990
• Effects of MK-801 upon Local Cerebral Glucose Utilisation in Conscious Rats and in Rats Anaesthetised with Halothane
  Journal of Cerebral Blood Flow & Metabolism, 1989
• 1‐Hydroxy‐3‐amino‐pyrrolidone‐2 (HA‐966): a new GABA‐like compound, with potential use in extrapyramidal diseases
  British Journal of Pharmacology, 1971